{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:17:15Z","timestamp":1783477035153,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014630","name":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014630","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011045","name":"Minist\u00e8re de l'Enseignement sup\u00e9rieur, de la Recherche et de l'Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","award":["ANR-23-CE15-0039-01"],"award-info":[{"award-number":["ANR-23-CE15-0039-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.isci.2025.114226","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:50:16Z","timestamp":1764175816000},"page":"114226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Viral clearance and escape during therapy of COVID-19 outpatients: A prospective cohort study"],"prefix":"10.1016","volume":"28","author":[{"given":"Guillaume","family":"Martin-Blondel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Burgat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Leducq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Porrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cottignies-Calamarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"De Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Dorival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaelle","family":"Romieu-Mourez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Chaubet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Cazaentre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Boumaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Richier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Gaborit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Coustilleres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Dub\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Ader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youri","family":"Yordanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Genevi\u00e8ve","family":"Marcelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clovis","family":"Lusivika-Nzinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Carrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathia","family":"Souli\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Liblau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timoth\u00e9e","family":"Bruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.114226_bib1","article-title":"Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study","volume":"35","author":"Evans","year":"2023","journal-title":"Lancet Reg. Health. Eur."},{"key":"10.1016\/j.isci.2025.114226_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.01.009","article-title":"Disparities in COVID-19 mortality amongst the immunosuppressed: A systematic review and meta-analysis for enhanced disease surveillance","volume":"88","author":"Leston","year":"2024","journal-title":"J. Infect."},{"key":"10.1016\/j.isci.2025.114226_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adk1599","article-title":"SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency","volume":"16","author":"Li","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2025.114226_bib4","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.cell.2020.10.049","article-title":"Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer","volume":"183","author":"Avanzato","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.114226_bib5","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMc2031364","article-title":"Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host","volume":"383","author":"Choi","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.114226_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-021-03291-y","article-title":"SARS-CoV-2 evolution during treatment of chronic infection","volume":"592","author":"Kemp","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.114226_bib7","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMsb2104756","article-title":"SARS-CoV-2 Variants in Patients with Immunosuppression","volume":"385","author":"Corey","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.114226_bib8","doi-asserted-by":"crossref","first-page":"e883","DOI":"10.1016\/S2666-5247(23)00194-5","article-title":"Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis","volume":"4","author":"Stadler","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.isci.2025.114226_bib9","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/jac\/dkae301","article-title":"Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial","volume":"79","author":"Beaulieu","year":"2024","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.isci.2025.114226_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-071932","article-title":"Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform","volume":"379","author":"Zheng","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.isci.2025.114226_bib11","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168603","article-title":"SARS-CoV-2 variants resistant to monoclonal antibodies in immunocompromised patients constitute a public health concern","volume":"133","author":"Casadevall","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2025.114226_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100991","article-title":"Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment","volume":"71","author":"Focosi","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.isci.2025.114226_bib13","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/infdis\/jiad523","article-title":"Spike Protein Genetic Evolution in Patients at High Risk of Severe Coronavirus Disease 2019 Treated by Monoclonal Antibodies","volume":"229","author":"Leducq","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.isci.2025.114226_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41579-021-00639-z","article-title":"Infectious disease in an era of global change","volume":"20","author":"Baker","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.isci.2025.114226_bib15","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41573-022-00495-3","article-title":"Antibodies to combat viral infections: development strategies and progress","volume":"21","author":"Pantaleo","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2025.114226_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166032","article-title":"Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments","volume":"133","author":"Gupta","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2025.114226_bib17","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.medj.2023.07.007","article-title":"Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients","volume":"4","author":"Bruel","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.isci.2025.114226_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg2783","article-title":"Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers","volume":"15","author":"Schmidt","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2025.114226_bib19","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1038\/s41375-025-02649-9","article-title":"Post-pandemic recommendations for the management of COVID-19 in patients with haematological malignancies or undergoing cellular therapy, from the European Conference on Infections in Leukaemia (ECIL-10)","volume":"39","author":"Cesaro","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.isci.2025.114226_bib20","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.cmi.2025.05.032","article-title":"Management of COVID-19 in immunocompromised patients: an European Society of Clinical Microbiology and Infectious Diseases consensus document","volume":"31","author":"Bartoletti","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.isci.2025.114226_bib21","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/S2666-5247(23)00393-2","article-title":"Effect of molnupiravir on SARS-CoV-2 evolution in immunocompromised patients: a retrospective observational study","volume":"5","author":"Fountain-Jones","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.isci.2025.114226_bib22","first-page":"1","article-title":"Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP.3.3 From Approved Monoclonal Antibodies. Pathog","volume":"10","author":"Planas","year":"2024","journal-title":"Immun"},{"key":"10.1016\/j.isci.2025.114226_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(25)00079-9","article-title":"Virological characteristics of the SARS-CoV-2 LP.8.1 variant","volume":"25","author":"Chen","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2025.114226_bib24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1473-3099(24)00812-0","article-title":"Sipavibart: when a success changes into a failure","volume":"25","author":"Focosi","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.isci.2025.114226_bib25","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1016\/j.jinf.2022.06.033","article-title":"Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2","volume":"85","author":"Martin-Blondel","year":"2022","journal-title":"J. Infect."},{"key":"10.1016\/j.isci.2025.114226_bib26","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2108163","article-title":"REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19","volume":"385","author":"Weinreich","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.114226_bib27","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa2107934","article-title":"Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab","volume":"385","author":"Gupta","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.114226_bib28","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S2213-2600(22)00180-1","article-title":"Efficacy and safety of intramuscular administration of tixagevimab\u2013cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"10","author":"Montgomery","year":"2022","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.isci.2025.114226_bib29","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.114226_bib30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2116846","article-title":"Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients","volume":"386","author":"Gottlieb","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.114226_bib31","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41467-024-44804-3","article-title":"Utility of long-read sequencing for All of Us","volume":"15","author":"Mahmoud","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.114226_bib32","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/s41592-023-01993-x","article-title":"Scalable Nanopore sequencing of human genomes provides a comprehensive view of haplotype-resolved variation and methylation","volume":"20","author":"Kolmogorov","year":"2023","journal-title":"Nat. Methods"},{"key":"10.1016\/j.isci.2025.114226_bib33","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s43588-022-00387-x","article-title":"Symphonizing pileup and full-alignment for deep learning-based long-read variant calling","volume":"2","author":"Zheng","year":"2022","journal-title":"Nat. Comput. Sci."},{"key":"10.1016\/j.isci.2025.114226_bib34","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41586-021-04389-z","article-title":"Considerable escape of SARS-CoV-2 Omicron to antibody neutralization","volume":"602","author":"Planas","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.114226_bib35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization","volume":"596","author":"Planas","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.114226_bib36","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/s41591-022-01792-5","article-title":"Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies","volume":"28","author":"Bruel","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2025.114226_bib37","article-title":"Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies","volume":"3","author":"Bruel","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2025.114226_bib38","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41591-021-01318-5","article-title":"Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies","volume":"27","author":"Planas","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2025.114226_bib39","article-title":"Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies","volume":"2","author":"Dufloo","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2025.114226_bib40","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.jinf.2022.04.010","article-title":"Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S COCOPREV study)","volume":"84","author":"Martin-Blondel","year":"2022","journal-title":"J Infection"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225024873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225024873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:56:12Z","timestamp":1783475772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225024873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2589004225024873"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.114226","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viral clearance and escape during therapy of COVID-19 outpatients: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.114226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114226"}}